NMAD
NOMAD Power Solutions, Inc. • NASDAQ
$5.88 ▲ 1.91% (+0.11)
NMAD
NOMAD Power Solutions, Inc.NASDAQ • $5.88 ▲ 1.91% (+0.11)
Market Cap $71.50 M
52w High $8.38
52w Low $2.36
P/E -32.67
Volume 691.55K
Outstanding Shares 12.36M
Market Cap $71.50 M
52w High $8.38
52w Low $2.36
P/E -32.67
Volume 691.55K
Outstanding Shares 12.36M
About NOMAD Power Solutions, Inc.
http://www.lixte.comLixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets.
CEO
Geordan G. Pursglove
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public November 24, 2020
Method of going public Reverse Merger
Full time employees 3
ETFs Holding This Stock
Summary
Total 3
Showing Top 1 of 3
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0